For questions and comments please contact Dr. Perry:
paul-perry@uiowa.edu
- Awards, Reviews and Comments
- Treatment of Acute Functional
Psychosis
- Pharmacologic Management of Organic
Agitation
- Treatment of Refractory
Schizophrenia
- Atypical Antipsychotics
- Neuroleptic Maintenance Therapy
- Antipsychotic Dosing
- Early-Onset Extrapyramidal Side
Effects
- Tardive Dyskinesia
- Serotonin Syndrome and Neuroleptic Malignant
Syndrome
- Pharmacotherapy of Depression
- Treatment of Refractory Depression
- The Pharmacotherapy of Late-Life
Depression
- Selective Serotonin Reuptake
Inhibitors
- Pharmacotherapy for Major Depression with
Melancholic Features: Relative Efficacy of Tricyclic Versus
Selective Serotonin Reuptake Inhibitor Antidepressants
- Venlafaxine
(Effexor®)
- Nefazodone
(Serzone®)
- Antidepressant Dosing
- Cardiovascular Effects of Tricyclic and
Second-Generation Antidepressants
- Monoamine Oxidase Inhibitors: Adverse
Effects
- Antimanics
- Drug Therapy in the Prevention of Relapse and Recurrence in Affective
Disorder
- Mood Stabilizer Dosing
- Mood Stablizer Adverse Effects
- Anticholinergic Psychosis
- Stimulant Psychosis
- Steroid-Induced Mental Disturbances
- LSD Psychosis
- Phencyclidine Intoxication
- Marijuana Mental Disturbances
- Antidepressant Overdose and
Treatment
- Lithium Intoxication
- Detoxification from Benzodiazepines:
Schedules and Strategies
- Management of Opiate Withdrawal
- Pharmacologic Treatment of Panic
Disorder
- Benzodiazepine Treatment of Generalized
Anxiety Disorder
- Obsessive Compulsive Disorder
Pharmacotherapy
- Posttraumatic Stress Disorder
- Attention-Deficit Hyperactivity Disorder
Pharmacotherapy
- Pediatric Psychopharmacology:
Depression
- Pediatric Psychopharmacology:
Autism
- Pediatric Psychopharmacology: Tourette's
Syndrome
- Pediatric Psychopharmacology: Nocturnal
Enuresis and Encopresis
- Pharmacotherapy of Eating Disorders
- Cognitive Enhancers and Neuroprotective
Agents
Cases and Tests
Title Page